<?xml version="1.0" encoding="UTF-8"?>
<ref id="B19-pharmaceuticals-14-00381">
 <label>19.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Watkins</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Resch</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Irlbeck</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Swanstrom</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>Selection of high-level resistance to human immunodeficiency virus type 1 protease inhibitors</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2003</year>
  <volume>47</volume>
  <fpage>759</fpage>
  <lpage>769</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.47.2.759-769.2003</pub-id>
  <pub-id pub-id-type="pmid">12543689</pub-id>
 </element-citation>
</ref>
